{"title":"新碱、免疫球蛋白、糖皮质激素和霉酚酸酯(VIGM方案)联合治疗对PD-1阻断继发的3/4级或类固醇难治性免疫介导肝毒性(IMH)非常有效","authors":"Zhanhong Chen, Xiang-yuan Wu","doi":"10.1136/gutjnl-2023-iddf.135","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"IDDF2023-ABS-0110 Combination therapy with vincristine, immunoglobulin, glucocorticosteroid and mycophenolate mofetil (VIGM regimen) is very effective for the management of grade 3/4 or steroid-refractory immune-mediated hepatotoxicity (IMH) secondary to PD-1 blockade\",\"authors\":\"Zhanhong Chen, Xiang-yuan Wu\",\"doi\":\"10.1136/gutjnl-2023-iddf.135\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9921,\"journal\":{\"name\":\"Chinese Journal of Clinical Hepatology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chinese Journal of Clinical Hepatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/gutjnl-2023-iddf.135\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Clinical Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/gutjnl-2023-iddf.135","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
IDDF2023-ABS-0110 Combination therapy with vincristine, immunoglobulin, glucocorticosteroid and mycophenolate mofetil (VIGM regimen) is very effective for the management of grade 3/4 or steroid-refractory immune-mediated hepatotoxicity (IMH) secondary to PD-1 blockade